310 related articles for article (PubMed ID: 30995715)
1. LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.
Bonanno L; Zulato E; Pavan A; Attili I; Pasello G; Conte P; Indraccolo S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995715
[TBL] [Abstract][Full Text] [Related]
2.
Pons-Tostivint E; Lugat A; Fontenau JF; Denis MG; Bennouna J
Cells; 2021 Nov; 10(11):. PubMed ID: 34831355
[TBL] [Abstract][Full Text] [Related]
3. Loss of FGL1 induces epithelial‑mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Bie F; Wang G; Qu X; Wang Y; Huang C; Wang Y; Du J
Int J Oncol; 2019 Sep; 55(3):697-707. PubMed ID: 31322182
[TBL] [Abstract][Full Text] [Related]
4. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.
Koyama S; Akbay EA; Li YY; Aref AR; Skoulidis F; Herter-Sprie GS; Buczkowski KA; Liu Y; Awad MM; Denning WL; Diao L; Wang J; Parra-Cuentas ER; Wistuba II; Soucheray M; Thai T; Asahina H; Kitajima S; Altabef A; Cavanaugh JD; Rhee K; Gao P; Zhang H; Fecci PE; Shimamura T; Hellmann MD; Heymach JV; Hodi FS; Freeman GJ; Barbie DA; Dranoff G; Hammerman PS; Wong KK
Cancer Res; 2016 Mar; 76(5):999-1008. PubMed ID: 26833127
[TBL] [Abstract][Full Text] [Related]
5. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.
Ciccarese F; Zulato E; Indraccolo S
Oxid Med Cell Longev; 2019; 2019():8730816. PubMed ID: 31781355
[TBL] [Abstract][Full Text] [Related]
6. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
7. LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation.
Zulato E; Ciccarese F; Agnusdei V; Pinazza M; Nardo G; Iorio E; Curtarello M; Silic-Benussi M; Rossi E; Venturoli C; Panieri E; Santoro MM; Di Paolo V; Quintieri L; Ciminale V; Indraccolo S
Biochem Pharmacol; 2018 Oct; 156():479-490. PubMed ID: 30222967
[TBL] [Abstract][Full Text] [Related]
8. [Vascular normalization and cancer immunotherapy].
Zeng J; Yuan D; Liu H; Song Y
Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):273-6. PubMed ID: 24667268
[TBL] [Abstract][Full Text] [Related]
9. Liver kinase B1 suppresses the metastasis and angiogenesis of lung cancer: involvement of the Shh signaling pathway.
Zheng G; Song K; Zhao Y
Neoplasma; 2019 May; 66(3):367-376. PubMed ID: 30784288
[TBL] [Abstract][Full Text] [Related]
10. Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells.
Zhang C; Xiao X; Chen M; Aldharee H; Chen Y; Long W
Oncol Rep; 2018 Jan; 39(1):376-382. PubMed ID: 29138862
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis.
Okon IS; Coughlan KA; Zhang C; Moriasi C; Ding Y; Song P; Zhang W; Li G; Zou MH
J Clin Invest; 2014 Oct; 124(10):4590-602. PubMed ID: 25180605
[TBL] [Abstract][Full Text] [Related]
12. Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer.
Cao C; Gao R; Zhang M; Amelio AL; Fallahi M; Chen Z; Gu Y; Hu C; Welsh EA; Engel BE; Haura EB; Cress WD; Wu L; Zajac-Kaye M; Kaye FJ
J Natl Cancer Inst; 2015 Jan; 107(1):358. PubMed ID: 25465874
[TBL] [Abstract][Full Text] [Related]
13. The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.
Li HY; McSharry M; Bullock B; Nguyen TT; Kwak J; Poczobutt JM; Sippel TR; Heasley LE; Weiser-Evans MC; Clambey ET; Nemenoff RA
Cancer Immunol Res; 2017 Sep; 5(9):767-777. PubMed ID: 28819064
[TBL] [Abstract][Full Text] [Related]
14. Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose.
Inge LJ; Coon KD; Smith MA; Bremner RM
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):580-6. PubMed ID: 19258070
[TBL] [Abstract][Full Text] [Related]
15. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
16. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
Rodriguez-Nieto S; Sanchez-Cespedes M
Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640
[TBL] [Abstract][Full Text] [Related]
17. LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.
Li F; Han X; Li F; Wang R; Wang H; Gao Y; Wang X; Fang Z; Zhang W; Yao S; Tong X; Wang Y; Feng Y; Sun Y; Li Y; Wong KK; Zhai Q; Chen H; Ji H
Cancer Cell; 2015 May; 27(5):698-711. PubMed ID: 25936644
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
19. Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.
Nagaraj AS; Lahtela J; Hemmes A; Pellinen T; Blom S; Devlin JR; Salmenkivi K; Kallioniemi O; Mäyränpää MI; Närhi K; Verschuren EW
Cell Rep; 2017 Jan; 18(3):673-684. PubMed ID: 28099846
[TBL] [Abstract][Full Text] [Related]
20. LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab.
Bonanno L; De Paoli A; Zulato E; Esposito G; Calabrese F; Favaretto A; Santo A; Conte AD; Chilosi M; Oniga F; Sozzi G; Moro M; Ciccarese F; Nardo G; Bertorelle R; Candiotto C; De Salvo GL; Amadori A; Conte P; Indraccolo S
Clin Cancer Res; 2017 Jul; 23(13):3316-3324. PubMed ID: 28119362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
